General Electric’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-988,901
| Closed | -$115M | – | 189 |
|
|
2016
Q2 | $115M | Buy |
988,901
+116,900
| +13% | +$13.6M | 0.6% | 59 |
|
|
2016
Q1 | $121M | Sell |
872,001
-48,098
| -5% | -$6.7M | 0.62% | 55 |
|
|
2015
Q4 | $176M | Sell |
920,099
-9,805
| -1% | -$1.87M | 0.85% | 41 |
|
|
2015
Q3 | $145M | Sell |
929,904
-12,080
| -1% | -$1.89M | 0.35% | 49 |
|
|
2015
Q2 | $170M | Buy |
941,984
+141,500
| +18% | +$25.6M | 0.38% | 43 |
|
|
2015
Q1 | $139M | Buy |
800,484
+117,406
| +17% | +$20.3M | 0.32% | 55 |
|
|
2014
Q4 | $126M | Buy |
683,078
+2,482
| +0.4% | +$459K | 0.3% | 63 |
|
|
2014
Q3 | $113M | Buy |
680,596
+61,018
| +10% | +$10.1M | 0.29% | 66 |
|
|
2014
Q2 | $96.8M | Buy |
619,578
+133,373
| +27% | +$20.8M | 0.44% | 72 |
|
|
2014
Q1 | $74M | Sell |
486,205
-4,114
| -0.8% | -$626K | 0.35% | 77 |
|
|
2013
Q4 | $65.2M | Buy |
490,319
+14,222
| +3% | +$1.89M | 0.31% | 80 |
|
|
2013
Q3 | $55.3M | Buy |
476,097
+405,483
| +574% | +$47.1M | 0.28% | 81 |
|
|
2013
Q2 | $6.51M | Buy |
+70,614
| New | +$6.51M | 0.03% | 147 |
|